ESC 365 - Relative efficacy of spironolactone, eplerenone, and canrenone in patients with chronic systolic heart failure - a systematic review and network meta-analysis of randomized controlled trials

HFA Premium Access

Relative efficacy of spironolactone, eplerenone, and canrenone in patients with chronic systolic heart failure - a systematic review and network meta-analysis of randomized controlled trials

Session: Poster Session 3 - Chronic Heart Failure – Treatment

Topic: Pharmacotherapy

Speaker: Associate Professor L. Frankenstein (Heidelberg, DE)

Event: Heart Failure 2018

Congress Presentation

Add to my library

About the speaker

Associate Professor Lutz Frankenstein

University Hospital Heidelberg, Heidelberg (Germany)

0 follower

38 more presentations in this session

Tertiary heart failure care in the netherlands: what is the added value

Speaker: Miss M. Vester (Leiden, NL)

The protective effect of beta-blockers in 3,278 advanced heart failure patients treated with continuous inotropes

Speaker: Doctor O. Havakuk (Tel Aviv, IL)

The benefits of ivabradine in the management of angina pectoris and heart failure.

Speaker: Doctor Z. RAISSUNI (Tanger, MA)

Anti diabetic therapy in patients with heart failure and type 2 diabetes mellitus in general population.

The association between adherence to evidence-based medicines and outcomes in seniors with heart failure: a landmark analysis

Access the full session

Poster Session 3 - Chronic Heart Failure – Treatment

Speakers: Associate Professor L. Frankenstein, Miss M. Vester, Doctor O. Havakuk, Doctor Z. RAISSUNI

About the event

Heart Failure 2018

26 May - 29 May 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources